News | Medical Marketing & Media | MM&M

News

The latest news from the healthcare marketing and communications sector including pharmaceutical, biotech and medical device companies — and the brands they promote — as well as agencies, media and legislators.

Black and Hispanic communities are lagging in getting vaccinated. How these organizations are trying to change that
Black and Hispanic communities are lagging in getting vaccinated. How these organizations are trying to change that
Eric Berger
September 10, 2021
2:58 pm

Healthcare organizations are using personal connections and non-medical endorsers to convince hold-outs to get COVID-19 vaccines.

The Considered debuts with an eye on health-tech, DE&I
The Considered debuts with an eye on health-tech, DE&I
Lecia Bushak
September 10, 2021
2:29 pm

The agency is headed by former Havas Lynx CEO Dave Hunt.

Choose your own adventure
Choose your own adventure
Lecia Bushak
September 10, 2021
10:30 am

As healthcare companies seek to bulk up their data and analytics offerings, the choice often comes down to a simple question: Build or buy?

Five things for health marketers to know: Friday, September 10, 2021
Five things for health marketers to know: Friday, September 10, 2021
Lecia Bushak
September 10, 2021
5:00 am

Biden to push private employers to mandate vaccinations; 5 million e-cigarette products to be removed from market; Apellis eye disease treatment fails in “carbon copy” study.

AbelsonTaylor adds sr. account director for work on consumer brands
AbelsonTaylor adds sr. account director for work on consumer brands
MM+M Staff
September 9, 2021
1:58 pm

Kristin Glunz returns to the agency after six years away.

How communicators can reach the vaccine-hesitant
How communicators can reach the vaccine-hesitant
Sabrina Sanchez
September 9, 2021
1:23 pm

Those who are skeptical about the COVID-19 vaccine or refuse to get one altogether are politically disengaged, and therefore best reached through unconventional channels.

In pricing debate, is pharma ‘just along for the ride’?
In pricing debate, is pharma ‘just along for the ride’?
Lecia Bushak
September 9, 2021
12:05 pm

As Congress inches toward the inclusion of drug pricing reform in the upcoming reconciliation bill, the industry has only so many cards left to play.

The Art of the <strike>Possible</strike> Doable
The Art of the Possible Doable
Phillip Pantuso
September 9, 2021
11:30 am

How COVID-19 became a galvanizing event for the use of real-world data.

Five things for health marketers to know: Thursday, September 9, 2021
Five things for health marketers to know: Thursday, September 9, 2021
Lecia Bushak
September 9, 2021
5:00 am

Federal prosecutor accuses Holmes of “lying and cheating”; Replicate Bioscience to focus on mRNA technology in cancer; Pandemic sets back global battle against HIV, tuberculosis and malaria.

CrowdPharm, Cross & Wild set to merge
CrowdPharm, Cross & Wild set to merge
MM+M Staff
September 8, 2021
3:53 pm

The two indie agencies will unite under the CrowdPharm brand.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners